Skip to main content
INNOVA CAPTAB LIMITED logo

INNOVA CAPTAB LIMITED — Investor Relations & Filings

Ticker · INNOVACAP ISIN · INE0DUT01020 LEI · 549300SNL5HFUHE66804 BSE.NS Manufacturing
Open in API
Filings indexed 212 across all filing types
Latest filing 2024-01-11 Regulatory Filings
Country IN India
Listing BSE.NS INNOVACAP

About INNOVA CAPTAB LIMITED

https://www.innovacaptab.com

Innova Captab Limited is an integrated pharmaceutical company focused on the research, development, manufacturing, and marketing of a wide range of pharmaceutical formulations. The company operates primarily as a Contract Development and Manufacturing Organization (CDMO), providing comprehensive services to leading domestic and international pharmaceutical brands. Its product portfolio includes diverse dosage forms such as tablets, capsules, dry syrups, ointments, and injections across multiple therapeutic areas, including anti-infectives, analgesics, and gastrointestinal treatments. Innova Captab maintains a strong emphasis on R&D and quality control, operating advanced manufacturing facilities that adhere to global regulatory standards. In addition to its CDMO business, the company manages a domestic branded generics division and an international export business, catering to a global clientele with a focus on high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended December 31, 2023. It is a compliance certificate from the Registrar & Share Transfer Agent confirming no requests for dematerialization/rematerialization of shares during the quarter. The document is addressed to stock exchanges and is a regulatory compliance filing rather than a financial report or announcement of financial results. The document length is short (2449 characters) and it does not contain financial statements or detailed financial data. It is primarily a regulatory compliance certificate, fitting the definition of Regulatory Filings (RNS).
2024-01-11 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a letter from Innova Captab Limited addressed to stock exchanges informing about the closure of the trading window in compliance with SEBI regulations. It mentions the upcoming declaration of unaudited financial results for the quarter and nine months ended December 31, 2023, and the half year ended September 30, 2023. The document does not contain any financial data or results itself, nor does it include the actual financial report. It is an announcement related to trading restrictions ahead of financial results disclosure. The document length is short (2139 characters) and it serves as a regulatory compliance notice rather than a financial report or earnings release. Therefore, it fits best under Regulatory Filings (RNS).
2024-01-01 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.